Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma
- PMID: 12722939
- DOI: 10.1081/imm-120019205
Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma
Abstract
It has been seen that advanced stage oral squamous cell carcinoma is associated with impaired T-cell function and higher antibody response. In order to find out if such immune disregulation is associated with alteration of T-helper (Th) type CD4+ T-cell phenotype leading to altered cytokine production, we studied the Th-like cytokine profile in 35 oral squamous cell carcinoma patients and 21 normal controls. Concomitant expression of both Th1 and Th2 cytokine genes was studied by reverse transcription and Polymerase Chain Reaction (PCR) based amplification (RT-PCR) of mRNA extracted from freshly isolated peripheral blood mononuclear cells (PBMC) using specific primers for Interferon (IFN)-gamma, Interleukin (IL)-2, IL-4 and IL-10. Almost 63% of oral cancer patients showed polarization of a Th-like cytokine response as compared to 33% of the normal controls while 66.6% of normal controls showed a predominantly non-polarized Th0 response. Expression of IFN-gamma and IL-2 genes was more commonly seen in the early stage of the disease (p < 0.02) whereas majority of advanced stage tumours was associated with enhanced expression of IL-4 and IL-10 but not IFN-gamma and IL-2 genes. Patients with lymphnode metastases and poorly differentiated tumours expressed IL-4 and IL-10 more frequently with concomitant suppression of IFN-gamma and IL-2 genes. It seems therefore, that the development of oral squamous cell carcinoma leads to polarization of cytokine gene expression that is skewed towards the Th1-like response in the early stage. However, increasing tumour load and lymphnode invasion suppresses Th1 cytokine genes, thus skewing it toward a Th2-like cytokine response.
Similar articles
-
Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.Ann Surg. 1995 Oct;222(4):482-90; discussion 490-2. doi: 10.1097/00000658-199522240-00006. Ann Surg. 1995. PMID: 7574928 Free PMC article.
-
Selected Th1 and Th2 cytokine mRNA expression by CD4(+) T cells isolated from inflamed human gingival tissues.Clin Exp Immunol. 1996 Mar;103(3):422-8. doi: 10.1111/j.1365-2249.1996.tb08297.x. Clin Exp Immunol. 1996. PMID: 8608641 Free PMC article.
-
Cytokine profiles of in vivo activated thyroid-infiltrating T cells cloned in the presence or absence of interleukin 4.Autoimmunity. 1997;26(2):103-10. doi: 10.3109/08916939709003853. Autoimmunity. 1997. PMID: 9546811
-
T helper cytokines in dry eye disease.Exp Eye Res. 2013 Dec;117:118-25. doi: 10.1016/j.exer.2013.08.013. Epub 2013 Sep 4. Exp Eye Res. 2013. PMID: 24012834 Free PMC article. Review.
-
Th1 and Th2 cells.Curr Opin Hematol. 2001 Jan;8(1):47-51. doi: 10.1097/00062752-200101000-00009. Curr Opin Hematol. 2001. PMID: 11138626 Review.
Cited by
-
Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma.Front Oncol. 2021 Mar 17;11:604784. doi: 10.3389/fonc.2021.604784. eCollection 2021. Front Oncol. 2021. PMID: 33816236 Free PMC article.
-
Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO.BMC Cancer. 2007 Mar 5;7:40. doi: 10.1186/1471-2407-7-40. BMC Cancer. 2007. PMID: 17338814 Free PMC article.
-
Lentiviral vector-based therapy in head and neck cancer (Review).Oncol Lett. 2014 Jan;7(1):3-9. doi: 10.3892/ol.2013.1652. Epub 2013 Nov 1. Oncol Lett. 2014. PMID: 24348811 Free PMC article.
-
Eosinophils and oral squamous cell carcinoma: a short review.J Oncol. 2009;2009:310132. doi: 10.1155/2009/310132. Epub 2009 Dec 16. J Oncol. 2009. PMID: 20049171 Free PMC article.
-
MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.Cancer Immunol Immunother. 2004 Jun;53(6):525-32. doi: 10.1007/s00262-003-0486-4. Epub 2004 Jan 17. Cancer Immunol Immunother. 2004. PMID: 14730400 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials